Ruth M. Belin - Concepedia

Author

Ruth M. Belin

Eli Lilly (United States)

Also Known As

R Belin, R. Belin, R.M. Belin, Ruth Belin, Ruth M Belin, Ruth M. Belin

Publications

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Johns Hopkins University Icahn School of Medicine at Mount Sinai

About

Ruth M. Belin is an author at Eli Lilly (United States) specializing in medicine, gastroenterology, and digestive system diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	261
2	Gastroenterology	3	3	179
3	Immunology	2	2	167
4	Biochemistry	1	1	58
5	Diabetes	1	1	58

Ruth M. Belin

Publications

Citations

H-Index

Page 1

	Year	Citations
Serum TSH and Total T <sub>4</sub> in the United States Population and Their Association With Participant Characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002) Yutaka Aoki, Ruth M. Belin, Robert P. Clickner, Thyroid	2007	380
Smoke Exposure Is Associated with a Lower Prevalence of Serum Thyroid Autoantibodies and Thyrotropin Concentration Elevation and a Higher Prevalence of Mild Thyrotropin Concentration Suppression in the Third National Health and Nutrition Examination Survey (NHANES III) Ruth M. Belin, Brad C. Astor, Neil R. Powe, The Journal of Clinical Endocrinology & Metabolism	2004	235
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease Bruce E. Sands, Laurent Peyrin‐Biroulet, Jarosław Kierkuś, Gastroenterology Chronic Inflammatory DiseasesCrohn ’ImmunologyGastroenterologyClinical Gastroenterology	2021	143
A Safe and Cost‐Effective Short Hospital Stay Protocol to Identify Patients at Low Risk for the Development of Significant Hypocalcemia After Total Thyroidectomy Zayna Nahas, Tarik Y. Farrag, Frank R. Lin, The Laryngoscope	2006	83
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470) Chafiq Hamdouchi, Steven D. Kahl, Anjana Patel Lewis, Journal of Medicinal Chemistry PharmacotherapyInsulin SignalingTranslational PharmacologyMetabolic SyndromeMolecular Pharmacology	2016	58
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis Marla C. Dubinsky, Remo Panaccione, James D. Lewis, Crohn s & Colitis 360	2022	31
Experience with a cholinesterase histochemical technique for rectal suction biopsies in the diagnosis of Hirschsprung's disease Peter Trigg, Ruth M. Belin, S. Haberkorn, Journal of Clinical Pathology Cholinesterase-positive NervesPhysiologyHistopathologyMucosal Cholinesterase ActivityPathology	1974	24
1003 – Efficacy and Safety of Mirikizumab (LY3074828) in a Phase 2 Study of Patients with Crohn's Disease Bruce E. Sands, William J. Sandborn, Laurent Peyrin‐Biroulet, Gastroenterology InflammationGastrointestinal PharmacologyImmunologyGastroenterology– Efficacy	2019	24
Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine Julio Rosenstock, Freddy G. Eliaschewitz, Cory R. Heilmann, Diabetes Technology & Therapeutics	2009	16
132 EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE Bruce E. Sands, William J. Sandborn, Laurent Peyrin‐Biroulet, Gastroenterology GastroenterologyClinical GastroenterologyUlcerative ColitisMedicineDigestive System Diseases	2021	12

Page 1